The latest closing stock price for Compass Therapeutics as of January 21, 2025 is 2.61.
An investor who bought $1,000 worth of Compass Therapeutics stock at the IPO in 2021 would have $-265 today, roughly 0 times their original investment - a -9.75% compound annual growth rate over 3 years.
The all-time high Compass Therapeutics stock closing price was 5.48 on January 10, 2023.
The Compass Therapeutics 52-week high stock price is 2.73, which is 4.6% above the current share price.
The Compass Therapeutics 52-week low stock price is 0.77, which is 70.5% below the current share price.
The average Compass Therapeutics stock price for the last 52 weeks is 1.54.
An investor who bought $1,000 worth of Compass Therapeutics stock at the IPO in 2021 would have $-265 today, roughly 0 times their original investment - a -9.75% compound annual growth rate over 3 years.
The all-time high Compass Therapeutics stock closing price was 5.48 on January 10, 2023.
The Compass Therapeutics 52-week high stock price is 2.73, which is 4.6% above the current share price.
The Compass Therapeutics 52-week low stock price is 0.77, which is 70.5% below the current share price.
The average Compass Therapeutics stock price for the last 52 weeks is 1.54.